High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs

Neuron. 2019 Aug 7;103(3):432-444.e3. doi: 10.1016/j.neuron.2019.05.031. Epub 2019 Jun 17.

Abstract

Subtypes of nucleus accumbens medium spiny neurons (MSNs) promote dichotomous outcomes in motivated behaviors. However, recent reports indicate enhancing activity of either nucleus accumbens (NAc) core MSN subtype augments reward, suggesting coincident MSN activity may underlie this outcome. Here, we report a collateral excitation mechanism in which high-frequency, NAc core dopamine 1 (D1)-MSN activation causes long-lasting potentiation of excitatory transmission (LLP) on dopamine receptor 2 (D2)-MSNs. Our mechanistic investigation demonstrates that this form of plasticity requires release of the excitatory peptide substance P from D1-MSNs and robust cholinergic interneuron activation through neurokinin receptor stimulation. We also reveal that D2-MSN LLP requires muscarinic 1 receptor activation, intracellular calcium signaling, and GluR2-lacking AMPAR insertion. This study uncovers a mechanism for shaping NAc core activity through the transfer of excitatory information from D1-MSNs to D2-MSNs and may provide a means for altering goal-directed behavior through coordinated MSN activity.

Keywords: AMPAR insertion; D2-MSNs; cholinergic interneurons; excitatory potentiation; long-lasting potentiation; muscarinic receptors; nucleus accumbens; phospholipase C signaling; substance P; synaptic plasticity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Action Potentials / physiology
  • Animals
  • Aprepitant / pharmacology
  • Calcium Signaling / physiology
  • Cholinergic Neurons / physiology
  • Dopaminergic Neurons / physiology*
  • Dopaminergic Neurons / radiation effects
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Interneurons / physiology
  • Long-Term Potentiation / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Motivation
  • Neurokinin-1 Receptor Antagonists / pharmacology
  • Nucleus Accumbens / cytology
  • Nucleus Accumbens / physiology*
  • Photic Stimulation
  • Piperidines / pharmacology
  • Receptor, Muscarinic M1 / physiology
  • Receptors, AMPA / physiology
  • Receptors, Dopamine D1 / analysis
  • Receptors, Dopamine D2 / analysis
  • Receptors, Neurokinin-1 / physiology
  • Substance P / metabolism*

Substances

  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • Receptor, Muscarinic M1
  • Receptors, AMPA
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Neurokinin-1
  • 3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine
  • Aprepitant
  • Substance P